Insulin Action under Arrestin

Slides:



Advertisements
Similar presentations
Individualized Medicine from Prewomb to Tomb Eric J. Topol Cell Volume 157, Issue 1, Pages (March 2014) DOI: /j.cell Copyright.
Advertisements

Mitoconfusion: Noncanonical Functioning of Dynamism Factors in Static Mitochondria of the Heart Moshi Song, Gerald W. Dorn Cell Metabolism Volume 21, Issue.
Making Proteins in the Powerhouse B. Martin Hällberg, Nils-Göran Larsson Cell Metabolism Volume 20, Issue 2, Pages (August 2014) DOI: /j.cmet
Functions of mitochondrial ISCU and cytosolic ISCU in mammalian iron-sulfur cluster biogenesis and iron homeostasis Wing-Hang Tong, Tracey A. Rouault Cell.
Nuclear Receptors, RXR, and the Big Bang Ronald M. Evans, David J. Mangelsdorf Cell Volume 157, Issue 1, Pages (March 2014) DOI: /j.cell
Human Brown Adipose Tissue Sven Enerbäck Cell Metabolism Volume 11, Issue 4, Pages (April 2010) DOI: /j.cmet Copyright © 2010.
The Metabolic Basis of Pulmonary Arterial Hypertension Gopinath Sutendra, Evangelos D. Michelakis Cell Metabolism Volume 19, Issue 4, Pages (April.
Lipin-1 Regulates Autophagy Clearance and Intersects with Statin Drug Effects in Skeletal Muscle Peixiang Zhang, M. Anthony Verity, Karen Reue Cell Metabolism.
SRC-3 Coactivator Functional Lifetime Is Regulated by a Phospho-Dependent Ubiquitin Time Clock Ray-Chang Wu, Qin Feng, David M. Lonard, Bert W. O'Malley.
Germline Energetics, Aging, and Female Infertility Jonathan L. Tilly, David A. Sinclair Cell Metabolism Volume 17, Issue 6, Pages (June 2013) DOI:
Oxygen Sensors at the Crossroad of Metabolism Julián Aragonés, Peter Fraisl, Myriam Baes, Peter Carmeliet Cell Metabolism Volume 9, Issue 1, Pages
Volume 4, Issue 1, Pages (July 2006)
p53 aerobics: The major tumor suppressor fuels your workout
Volume 14, Issue 2, Pages (August 2011)
Ghrelin—a new player in glucose homeostasis?
Making Muscle or Mitochondria by Selective Splicing of PGC-1α
Jochen G. Schneider, Joseph H. Nadeau  Cell Metabolism 
Something Old, Something New, Something Borrowed …
IRS-1: Auditing the effectiveness of mTOR inhibitors
All roads lead to FoxO Cell Metabolism
AMPK-Dependent Phosphorylation of ULK1 Induces Autophagy
Pancreatic β cells: Responding to the matrix
Serotonin and the Orchestration of Energy Balance
The Akt-mTOR tango and its relevance to cancer
Gal3 Links Inflammation and Insulin Resistance
Volume 15, Issue 1, Pages (January 2012)
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer  Vassiliki Papadimitrakopoulou,
PHLPPing It off: Phosphatases Get in the Akt
High T Gives β Cells a Boost
PTEN Enters the Nuclear Age
PKB Binding Proteins Cell
IRS1-Independent Defects Define Major Nodes of Insulin Resistance
Independent Control of Aging and Axon Regeneration
Insulin biosynthesis: The IREny of it all
Volume 26, Issue 1, Pages 6-7 (July 2017)
The CAMplexities of Central Ghrelin
AMPK Promotes Autophagy by Facilitating Mitochondrial Fission
Imbalanced Insulin Actions in Obesity and Type 2 Diabetes: Key Mouse Models of Insulin Signaling Pathway  Tetsuya Kubota, Naoto Kubota, Takashi Kadowaki 
Eukaryotic Transcription Activation: Right on Target
Characterizing the Killer Colorectal Carcinomas
IRS-1: Auditing the effectiveness of mTOR inhibitors
IL-6 Muscles In on the Gut and Pancreas to Enhance Insulin Secretion
Metformin and Insulin Meet in a Most Atypical Way
Modifying Mitochondrial tRNAs: Delivering What the Cell Needs
T Cells Are Smad’ly in Love with Galectin-9
Silencing Insulin Resistance through SIRT1
Estrogen Receptors and the Metabolic Network
AKT/PKB Signaling: Navigating Downstream
Signalling links in the liver: Knitting SOCS with fat and inflammation
Harding H. Luan, Ruslan Medzhitov  Cell Metabolism 
Iron Sensing as a Partnership: HFE and Transferrin Receptor 2
mTOR and Akt Signaling in Cancer: SGK Cycles In
Volume 14, Issue 2, Pages (August 2011)
Yvonne Ng, Georg Ramm, Jamie A. Lopez, David E. James  Cell Metabolism 
Brian K. Kennedy, Dudley W. Lamming  Cell Metabolism 
Cellular iron: Ferroportin is the only way out
An IRKO in the Podo: Impaired Insulin Signaling in Podocytes and the Pathogenesis of Diabetic Nephropathy  Susan B. Gurley, Thomas M. Coffman  Cell Metabolism 
Ann Marie Schmidt, Kathryn J. Moore  Cell Metabolism 
Volume 104, Issue 4, Pages (February 2001)
p53 aerobics: The major tumor suppressor fuels your workout
Collecting new targets in MODY
Hap1 and GABA: Thinking about food intake
Volume 24, Issue 1, Pages 7-8 (July 2016)
Should I Stay or Should I Go: A Clash of α-Cell Identity
Of Mice and Men: Not ExAKTly the Same?
Many Roads Lead to the Lipid Droplet
AMPK and p53 help cells through lean times
The Ups and Downs of Src Regulation: Tumor Suppression by Cbp
Tackling Resistance to PI3K Inhibition by Targeting the Epigenome
The Ribosome and TORC2: Collaborators for Cell Growth
Presentation transcript:

Insulin Action under Arrestin Jacqueline Stöckli, David E. James  Cell Metabolism  Volume 9, Issue 3, Pages 213-214 (March 2009) DOI: 10.1016/j.cmet.2009.02.005 Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 1 Models of Akt Activation (A) The conventional model for regulation of Akt by insulin involves tyrosine phosphorylation of IRS1, which recruits PI3K to the plasma membrane, where it generates PIP3. PIP3 acts as a docking site for PDKs and Akt leading to the phosphorylation of Akt on Thr308 and Ser473, concomitant with its activation. (B) Luan et al. propose a two-step model for Akt activation whereby insulin triggers the assembly of a tetrameric complex comprising insulin receptor, β-arrestin-2, c-Src, and Akt. This allows c-Src to phosphorylate Akt on Tyr315 and Tyr326 (step 1), and this step is somehow required (step 2) for phosphorylation of Akt at Thr308 and Ser473 (step 3) and its full activation. Luan et al. showed that impairment of c-Src function using PP2 or deletion of β-arrestin-2 inhibited tyrosine phosphorylation of Akt and its activation. Cell Metabolism 2009 9, 213-214DOI: (10.1016/j.cmet.2009.02.005) Copyright © 2009 Elsevier Inc. Terms and Conditions